EPO Patent EP4499128A1: Ligand Potentiation Methods
Summary
The European Patent Office published patent application EP4499128A1 on March 18, 2026, detailing methods and compositions for ligand potentiation. The patent lists Mark W. Grinstaff, Jack R. Kirsch, and Amanda K. Williamson as applicants and inventors.
What changed
This document is a publication of a European patent application (EP4499128A1) related to methods and compositions for potentiating a ligand. The patent application was published on March 18, 2026, and lists Mark W. Grinstaff, Jack R. Kirsch, and Amanda K. Williamson as the inventors and applicants. The International Patent Classification (IPC) codes indicate relevance to pharmaceutical preparations and therapeutic uses.
As this is a patent publication, it does not impose direct compliance obligations or deadlines on regulated entities. However, it may be of interest to pharmaceutical companies and drug manufacturers involved in research and development, as it pertains to novel methods and compositions in the field of ligand potentiation. Legal and R&D departments should review this publication for potential intellectual property considerations and competitive intelligence.
Source document (simplified)
METHODS AND COMPOSITIONS FOR POTENTIATION OF A LIGAND
Publication EP4499128A1 Kind: A1 Mar 18, 2026
Applicants
Grinstaff, Mark W., Kirsch, Jack R., Williamson, Amanda K.
Inventors
Grinstaff, Mark W., Kirsch, Jack R., Williamson, Amanda K.
IPC Classifications
A61K 38/22 20060101AFI20260210BHEP A61K 31/573 20060101ALI20260210BHEP A61P 7/04 20060101ALI20260210BHEP A61K 45/06 20060101ALI20260210BHEP A61K 9/00 20060101ALI20260210BHEP A61K 31/167 20060101ALI20260210BHEP A61K 9/16 20060101ALI20260210BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Pharma (A61K) publishes new changes.